Search for other papers by Fan Wu in
Google Scholar
PubMed
Search for other papers by Michael Nerlich in
Google Scholar
PubMed
Search for other papers by Denitsa Docheva in
Google Scholar
PubMed
elucidated Kohler at al 30 Bi et al 31 Perivascular cell Pericyte Tendon mesenchymal stem cell (TMSC) Vessel, paratenon, epitenon, tendon sheets Regulation of stem cells; regeneration of various tissues; immunomodulation Tempfer et al
School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
Search for other papers by Hsiao-Yi Cheng in
Google Scholar
PubMed
Department of Primary Care Medicine, Shuang Ho Hospital, Taipei Medical University, Taipei, Taiwan
Search for other papers by Chun-Wei Liang in
Google Scholar
PubMed
Department of Physical Medicine and Rehabilitation, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
Search for other papers by Yu-Hao Lee in
Google Scholar
PubMed
Search for other papers by Timporn Vitoonpong in
Google Scholar
PubMed
Master’s Program in Long-Term Care, College of Nursing, Taipei Medical University, Taipei, Taiwan
Search for other papers by Chun-De Liao in
Google Scholar
PubMed
Department of Physical Medicine and Rehabilitation, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
Search for other papers by Shih-Wei Huang in
Google Scholar
PubMed
, hyaluronic acids, platelet-rich plasma (PRP), platelet rich in growth factor (PRGF), botulinum toxin A, O 2 –O 3 , dextrose, and mesenchymal stem cell (MSC). Regarding exercise, most studies included resistance training programs to strengthen the quadriceps
Search for other papers by Enrique Gómez-Barrena in
Google Scholar
PubMed
Search for other papers by Christian Ehrnthaller in
Google Scholar
PubMed
( 12 ) and also a decrease in proliferation and differentiation of mesenchymal stem cells (MSCs) ( 13 ), which may suggest a systemic mesenchymal and osteogenic cell pool defect in patients sustaining this type of lesion. Those are the non-unions that
IRCCS Galeazzi Orthopedic Institute, Milan, Italy
Search for other papers by Luca Pierannunzii in
Google Scholar
PubMed
IRCCS Galeazzi Orthopedic Institute, Milan, Italy
Search for other papers by Luigi Zagra in
Google Scholar
PubMed
is the passive ability of a scaffold to be progressively substituted by viable bone; osteoinductivity is the capacity to stimulate the osteoblastic differentiation of local adult stem cells (i.e. mesenchymal stem cells, MSCs) through specific growth
IRCCS Humanitas Research Hospital, Milan, Italy
These authors contributed equally to the article and should both be considered first authors
Search for other papers by Gerardo Fusco in
Google Scholar
PubMed
IRCCS Humanitas Research Hospital, Milan, Italy
These authors contributed equally to the article and should both be considered first authors
Search for other papers by Francesco M. Gambaro in
Google Scholar
PubMed
First Moscow State Medical University – Sechenov University, Moscow, Russia
Search for other papers by Berardo Di Matteo in
Google Scholar
PubMed
IRCCS Humanitas Research Hospital, Milan, Italy
Search for other papers by Elizaveta Kon in
Google Scholar
PubMed
products we include corticosteroids (CS), hyaluronic acid (HA), polynucleotides, oxygen-ozone therapy, platelet-rich plasma (PRP) and mesenchymal stem cells (MSCs). CS and HA are ranked first as the most frequently injected substances and their use is
Search for other papers by Mukai Chimutengwende-Gordon in
Google Scholar
PubMed
Search for other papers by James Donaldson in
Google Scholar
PubMed
Search for other papers by George Bentley in
Google Scholar
PubMed
stimulation is to penetrate the subchondral bone plate with an awl, allowing a fibrin clot containing mesenchymal stem cells to be produced in the defect. 11 The mesenchymal stem cells are able to differentiate into fibrochondrocytes, leading to
Search for other papers by Minghe Yao in
Google Scholar
PubMed
Search for other papers by Tingkui Wu in
Google Scholar
PubMed
Search for other papers by Beiyu Wang in
Google Scholar
PubMed
#4 (‘pulposus-derived mesenchymal stem cell’; 88; 2015; S = 0.879; Sakai & Andersson ( 72 )), the trend came into cluster #3 (‘interventional pain physician’; 126; 2017; S = 0.807; Noriega et al. ( 43 )) while branching into two related clusters
Search for other papers by Enrique Gómez-Barrena in
Google Scholar
PubMed
Search for other papers by Norma G. Padilla-Eguiluz in
Google Scholar
PubMed
Search for other papers by Philippe Rosset in
Google Scholar
PubMed
the other 76% proposed the use of autologous cells. Treatments included percutaneously aspirated autologous bone marrow cells ( n = 1), pre-osteoblast cells from bone marrow ( n = 2), and mesenchymal stem cells from bone marrow ( n = 9). Two trials
Berlin Institute of Health at Charité – Universitätsmedizin Berlin, Julius Wolff Institute, Berlin, Germany
Berlin Institute of Health Center for Regenerative Therapies, Berlin Institute of Health at Charité – Universitätsmedizin Berlin, Berlin, Germany
Search for other papers by Tobias Winkler in
Google Scholar
PubMed
Berlin Institute of Health Center for Regenerative Therapies, Berlin Institute of Health at Charité – Universitätsmedizin Berlin, Berlin, Germany
Search for other papers by Sven Geissler in
Google Scholar
PubMed
Trauma Orthopaedic Research Copenhagen Hvidovre (TORCH), Department of Orthopaedic Surgery, Copenhagen University Hospital - Amager and Hvidovre, Hvidovre, Denmark
Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Tazio Maleitzke in
Google Scholar
PubMed
Search for other papers by Carsten Perka in
Google Scholar
PubMed
Berlin Institute of Health at Charité – Universitätsmedizin Berlin, Julius Wolff Institute, Berlin, Germany
Berlin Institute of Health Center for Regenerative Therapies, Berlin Institute of Health at Charité – Universitätsmedizin Berlin, Berlin, Germany
Search for other papers by Georg N Duda in
Google Scholar
PubMed
Berlin Institute of Health at Charité – Universitätsmedizin Berlin, Julius Wolff Institute, Berlin, Germany
Search for other papers by Alexander Hildebrandt in
Google Scholar
PubMed
E Aggelidou E & Kritis A . Bone regeneration with mesenchymal stem cells in scaffolds: systematic review of human clinical trials . Stem Cell Reviews and Reports 2024 20 938 – 966 . ( https://doi.org/10.1007/s12015-024-10696-5 ) 35
Search for other papers by Akintunde George in
Google Scholar
PubMed
Search for other papers by Marianne Ellis in
Google Scholar
PubMed
Search for other papers by Harinderjit Singh Gill in
Google Scholar
PubMed
differentiating along the osteogenic, adipogenic and chondrogenic lineages as previously demonstrated by numerous studies. Potier and Ferreira et al described in their own study that temporary exposure of mesenchymal stem cells to hypoxia leads to limited
